Last checked at TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV
TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV
26 Aug 21 12:53
- Home
- Share Prices
- AQSE Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Brokers
- Finance Tools
- Members
Latest Share Chat
Scancell Holdings Share News (SCLP)
SCLP Share
Price
SCLP Share
News
SCLP Share
Chat
SCLP Share
Trades30
SCLP
Live RNS
SCLP Share
Charts
SCLP Level 2
Console
SCLP Live
Share Price
SCLP Broker
Ratings
SCLP Directors
Deals
SCLP Financial
Diary
SCLP
Fundamentals
SCLP Short
Positions
SCLP
Media
SCLP Information
Share Price Information for Scancell Holdings (SCLP)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
22.10
Bid:
22.00
Ask:
22.20
Change:
-0.15
(-0.67%)
Spread:
0.20 (0.91%)
Open:
22.25
High:
22.50
Low:
22.10
Yest. Close:
22.25
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.26 Aug 21 12:53Scancell gets MHRA approval for Modi-1 clinical trial
(Sharecast News) - Immunotherapy developer Scancell announced on Thursday that the UK Medicines and Healthcare products Regulatory Authority (MHRA) has approved the clinical trial application to initiate the first-in-human phase 1 and 2 clinical study of 'Modi-1'.
26 Aug 21 12:38Scancell chooses needle-free tech for Covid vaccine candidates
(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell has selected the PharmaJet needle-free injection system to administer its two SARS-CoV-2 vaccine candidates for Covid-19, 'SCOV1' and 'SCOV2', in its 'COVIDITY' phase 1 clinical trial, it announced on Tuesday.
17 Aug 21 15:32DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares
DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares
30 Jul 21 14:24TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook
TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook
29 Jul 21 22:08IN BRIEF: Scancell turns once again to Durrant to lead company
IN BRIEF: Scancell turns once again to Durrant to lead company
28 Jul 21 22:00Scancell makes progress with 'Covidity' trial plans
(Sharecast News) - Immunotherapy developer Scancell updated the market on 'Covidity' clinical trial plans, and the publication of preclinical data on two vaccine candidates from the research programme.
22 Jun 21 15:21IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK
IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK
22 Jun 21 12:14IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares
IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares
7 Jun 21 13:58AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact
AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact
7 Jun 21 10:38IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares
IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares
30 Apr 21 14:30IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares
IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares
19 Feb 21 20:13IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares
IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares
19 Feb 21 12:40IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares
IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares
17 Feb 21 16:22Scancell ends clinical development partnership with Cancer Research UK
(Sharecast News) - Novel immunotherapy developer Scancell updated the market on its SCIB2 clinical development partnership with Cancer Research UK on Wednesday, reporting that due to the impact of the Covid-19 pandemic and Cancer Research UK's re-evaluation of its collaboration model, the parties had agreed to end their clinical development partnership.
3 Feb 21 14:53